KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biogen (BIIB) Profit After Tax (2016 - 2025)

Historic Profit After Tax for Biogen (BIIB) over the last 17 years, with Q4 2025 value amounting to -$48.9 million.

  • Biogen's Profit After Tax fell 11833.52% to -$48.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $1.3 billion, marking a year-over-year decrease of 2078.79%. This contributed to the annual value of $1.3 billion for FY2025, which is 2078.79% down from last year.
  • According to the latest figures from Q4 2025, Biogen's Profit After Tax is -$48.9 million, which was down 11833.52% from $466.5 million recorded in Q3 2025.
  • In the past 5 years, Biogen's Profit After Tax registered a high of $1.1 billion during Q3 2022, and its lowest value of -$68.3 million during Q3 2023.
  • Its 5-year average for Profit After Tax is $444.0 million, with a median of $391.0 million in 2024.
  • Per our database at Business Quant, Biogen's Profit After Tax skyrocketed by 278487.8% in 2022 and then tumbled by 11833.52% in 2025.
  • Biogen's Profit After Tax (Quarter) stood at -$20.5 million in 2021, then skyrocketed by 2784.88% to $550.4 million in 2022, then plummeted by 54.78% to $248.9 million in 2023, then grew by 7.15% to $266.7 million in 2024, then tumbled by 118.34% to -$48.9 million in 2025.
  • Its Profit After Tax was -$48.9 million in Q4 2025, compared to $466.5 million in Q3 2025 and $634.8 million in Q2 2025.